The following is a summary of "Advances and challenges in targeted therapies for HER2-amplified colorectal cancer," published ...

An ongoing clinical trial called "BREAKWATER" is showing great promise for metastatic colon cancer patients with a particular ...

Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw ...

A combination drug treatment doubled survival time for patients with an aggressive form of colorectal cancer, according to ...

The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient ...

Anlotinib plus chemotherapy demonstrated similar efficacy as bevacizumab plus chemotherapy for certain patients with ...

A team of researchers at the University of Minnesota recently completed a human trial for a novel gene-editing treatment, ...

Pfizer (PFE) stock gains as Braftovi combo shows survival benefits in a late-stage trial for metastatic colorectal cancer ...

The following is a summary of “Characteristics and role of surgery in nonagenarians with colorectal cancer: SEER database ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...